Cargando…

Vascular biomarkers and ApoE4 expression in mild cognitive impairment and Alzheimer's disease

Vascular pathology and genetic markers such as apolipoprotein E allele ε4 (ApoE ε4) are risk factors for the progression from mild cognitive impairment (MCI) to Alzheimer's disease (AD). In Panama, a high prevalence of vascular risk factors and an increase in the aging population, generate the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oviedo, Diana C., Lezcano, Hector, Perez, Ambar R., Villarreal, Alcibiades E., Carreira, Maria B., Isaza, Baltasar, Wesley, Lavinia, Grajales, Shantal A., Fernandez, Sara, Frank, Ana, Britton, Gabrielle B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AIMS Press 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181887/ https://www.ncbi.nlm.nih.gov/pubmed/32341958 http://dx.doi.org/10.3934/Neuroscience.2018.2.148

Ejemplares similares

The Role of Clinical Researchers During COVID-19: Balancing Individual, Scientific, and Social Benefits of Research
por: Oviedo, Diana C., et al.
Publicado: (2021)

Cognitive Impairment, Depression, and Cooccurrence of Both among the Elderly in Panama: Differential Associations with Multimorbidity and Functional Limitations
por: Villarreal, Alcibiades E., et al.
Publicado: (2015)

Inflammatory Biomarkers, Depressive Symptoms and Falls among the Elderly in Panama
por: Britton, Gabrielle B., et al.
Publicado: (2018)

Depression Mediates the Association Between Occupational Complexity and Late-Life Cognition in Hispanics
por: Posada Rodríguez, Camilo, et al.
Publicado: (2021)

A blood screening test for Alzheimer's disease
por: O'Bryant, Sid E., et al.
Publicado: (2016)

Vascular hypothesis of Alzheimer’s disease: role of apoE and apoE receptors
por: Bu, Guojun, et al.
Publicado: (2013)

Digital phenotyping: An equal opportunity approach to reducing disparities in Alzheimer's disease and related dementia research
por: Britton, Gabrielle B., et al.
Publicado: (2023)

A polygenic risk score for Alzheimer’s disease constructed using APOE-region variants has stronger association than APOE alleles with mild cognitive impairment in Hispanic/Latino adults in the U.S.
por: Sofer, Tamar, et al.
Publicado: (2023)

Vascular Dysfunction Is Central to Alzheimer’s Disease Pathogenesis in APOE e4 Carriers
por: McCorkindale, Andrew N., et al.
Publicado: (2022)

ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease
por: Apostolova, Liana G., et al.
Publicado: (2014)

First trimester screening using ultrasound and serum markers in Panamanians: Factors associated with adverse pregnancy outcomes
por: Herrera, Tania T., et al.
Publicado: (2014)

APOE genotype and Alzheimer’s immunotherapy
por: Pankiewicz, Joanna E., et al.
Publicado: (2017)

The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer’s Disease
por: Löwe, Luise Christine, et al.
Publicado: (2016)

APOE ɛ4 Allele and Financial Capacity Performance in Mild Alzheimer’s Disease: A Pilot Study
por: Giannouli, Vaitsa, et al.
Publicado: (2021)

The Effects of CSF Neurogranin and APOE ε4 on Cognition and Neuropathology in Mild Cognitive Impairment and Alzheimer’s Disease
por: Fan, Yulan, et al.
Publicado: (2021)

Association of CSF GAP-43 and APOE ε4 with Cognition in Mild Cognitive Impairment and Alzheimer’s Disease
por: Zhu, Yueli, et al.
Publicado: (2022)

Cerebrospinal fluid biomarkers for Alzheimer's and vascular disease vary by age, gender, and APOE genotype in cognitively normal adults
por: Li, Ge, et al.
Publicado: (2017)

Obesity Accelerates Alzheimer-Related Pathology in APOE4 but not APOE3 Mice
por: Moser, V. Alexandra, et al.
Publicado: (2017)

APOE Peripheral and Brain Impact: APOE4 Carriers Accelerate Their Alzheimer Continuum and Have a High Risk of Suicide in PM(2.5) Polluted Cities
por: Calderón-Garcidueñas, Lilian, et al.
Publicado: (2023)

APOE effects on regional tau in preclinical Alzheimer’s disease
por: Young, Christina B., et al.
Publicado: (2023)

Influence of APOE and RNF219 on Behavioral and Cognitive Features of Female Patients Affected by Mild Cognitive Impairment or Alzheimer’s Disease
por: Mosca, Alessandra, et al.
Publicado: (2018)

APOE-MS4A genetic interactions are associated with executive dysfunction and network abnormality in clinically mild Alzheimer's disease
por: Chang, Ya-Ting, et al.
Publicado: (2018)

Interaction between APOE ɛ4 genotype and education on mild cognitive impairment
por: Frank, M, et al.
Publicado: (2022)

Variation at APOE and STH loci and Alzheimer's disease
por: Zuo, Lingjun, et al.
Publicado: (2006)

The Role of Upregulated APOE in Alzheimer’s Disease Etiology
por: Gottschalk, William K, et al.
Publicado: (2016)

APOE4-mediated Alzheimer disease and “Vascular”—“Meningeal Lymphatic” components: towards a novel therapeutic era?
por: Chen, Zhangying, et al.
Publicado: (2021)

The COMT Val158 Met polymorphism as an associated risk factor for Alzheimer disease and mild cognitive impairment in APOE 4 carriers
por: Martínez, Manuel Fernández, et al.
Publicado: (2009)

APOE ɛ4 Gene Dose and Sex Effects on Alzheimer’s Disease MRI Biomarkers in Older Adults with Mild Cognitive Impairment
por: Hobel, Zachary, et al.
Publicado: (2019)

Decreased Global EEG Synchronization in Amyloid Positive Mild Cognitive Impairment and Alzheimer’s Disease Patients—Relationship to APOE ε4
por: Smailovic, Una, et al.
Publicado: (2021)

Apathy and APOE in mild behavioral impairment, and risk for incident dementia
por: Vellone, Daniella, et al.
Publicado: (2022)

APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases
por: Fernández-Calle, Rosalía, et al.
Publicado: (2022)

Protective effect of the APOE-e3 allele in Alzheimer's disease
por: de-Almada, B.V.P., et al.
Publicado: (2011)

Evaluation of APOE Genotype and Vascular Risk Factors As Prognostic and Risk Factors for Alzheimer’s Disease and Their Influence On Age of Symptoms Onset
por: Novotni, Gabriela, et al.
Publicado: (2019)

Correction: APOE4-mediated Alzheimer disease and “Vascular”—“Meningeal Lymphatic” components: towards a novel therapeutic era?
por: Chen, Zhangying, et al.
Publicado: (2021)

Association of the C47T Polymorphism in SOD2 with Amnestic Mild Cognitive Impairment and Alzheimer's Disease in Carriers of the APOEε4 Allele
por: Gamarra, David, et al.
Publicado: (2015)

Polygenic Risk Score Analysis of Alzheimer’s Disease in Cases without APOE4 or APOE2 Alleles
por: Escott-Price, V., et al.
Publicado: (2018)

ApoE Alzheimer’s Disease Aβ-amyloid plaque morphology varies according to APOE isotype
por: Caesar, Ina, et al.
Publicado: (2023)

APOE and Alzheimer’s Disease: Neuroimaging of Metabolic and Cerebrovascular Dysfunction
por: Brandon, Jason A., et al.
Publicado: (2018)

APOE2 is associated with longevity independent of Alzheimer’s disease
por: Shinohara, Mitsuru, et al.
Publicado: (2020)

APOE Alleles and Diet in Brain Aging and Alzheimer’s Disease
por: Yassine, Hussein N., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_37ttrhc65sit8vvka65sjtd1n4